Frank Mott

6PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyAboriginal and Torres Strait Islander and disabilityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 10, 2023
Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma.

Renata Ferrarotto, Luana G Sousa, Lei Feng

|Sep 22, 2021
Poziotinib for Patients With HER2 Exon 20 Mutant Non-Small-Cell Lung Cancer: Results From a Phase II Trial.

Yasir Y Elamin, Jacqulyne P Robichaux, Brett W Carter

|Dec 28, 2020
Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI).

Frank E Mott, Ruth Sacks, Faye Johnson

|Aug 21, 2020
End-of-life and goals of care discussions with cancer patients in the coronavirus pandemic.

Frank E Mott, Eduardo Bruera, Faye Johnson

|Aug 12, 2020
Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center.

Richard C Cardoso, Mona Kamal, Jhankruti Zaveri

|Jul 07, 2017
Patient Reported Outcomes (PROs) as Part of Value-Based Care Can Shape Therapy Guidelines: Impact on Emerging Targeted Agents and Immunotherapy Protocols in Resource-Limited Regions.

Frank E Mott

Pageof 1

Frequent Collaborators

2 joint publications

Katherine A Hutcheson

2 joint publications

Yasir Y Elamin

1 joint publications

Richard C Cardoso

1 joint publications

Mona Kamal